Skyline

SkylineDx

This company develops molecular diagnostic tests to help healthcare professionals personalise treatment decisions for patients with oncology and inflammatory diseases.

Delphi Diagnostics

This company develops genomic tests for breast cancer to assist clinicians and patients in personalising treatment decisions and predicting long-term survival outcomes.

Persona-Dx

The company develops artificial intelligence biomarker tests for tissue and blood samples to help oncologists personalise cancer diagnosis and treatment for metastatic patients.

Veracyte

This company develops genomic tests and diagnostic tools to help clinicians and patients make informed treatment decisions for various types of cancer.

Molecular Stethoscope

This company develops blood-based liquid biopsy tests that analyse cell-free messenger RNA to help clinicians and researchers detect and monitor diseases.

Single molecule diagnostics

This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.

NX Pharmagen

This company develops molecular diagnostic tests and imaging agents for physicians and healthcare payers to improve cancer and maternal-fetal health outcomes.

MetaSight

MetaSight Diagnostics develops multi-omics liquid biopsy tests for the early detection of chronic and acute diseases for healthcare providers and patients.